Skip to main content
OpenTrials
Completed

NCT Number: NCT02299024

Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter

The investigators overall study objective is to improve patients knowledge and safe use of opioid pain relievers upon discharge from the Emergency Department.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Northwestern University

Chicago, Illinois, 60611, United States

About this study

Recent studies indicate that emergency department (ED) discharge processes - including written and spoken communications - are inadequate, and patients often leave without the knowledge necessary to properly care for themselves. In the context of opioid pain relievers, this lack of knowledge is potentially dangerous, as patients may not possess the requisite knowledge for safe use of their medication or an awareness of the dangers of medication misuse.

The aim of this study was to evaluate the impact of an opioid information sheet and spoken counseling on patient knowledge about opioids and safe use behaviors. The investigators conducted a randomized controlled pilot test of a dual-modality educational intervention (written information sheet and spoken counseling about opioids) to assess if the intervention can increase patient knowledge about opioid pain relievers. These activities were intended to guide future modification of educational interventions and the future development of best practices for emergency physician spoken counseling about opioid pain relievers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • prescribed an opioid pain reliever
  • English Speaking

Exclusion criteria

  • Non-English Speaking
  • Clinically unstable, psychologically impaired or intoxicated as judged by the research staff member.
  • Chronic opioid use, defined as daily or near daily use of opioid pain relievers for the past 90 days.
  • admitted to hospital
  • unable to complete follow up phone interview in 4 - 7 days.

Treatment and study plan

Additional Opioid Information

Behavioral

Patients receiving this intervention are given additional information about the opioid pain medication that they are receiving in the form of a one page handout. The hand out was written in a health-literacy appropriate manner. A research assistant read the handout to them out loud, and they were given a copy to take home with them.

Primary outcomes

  1. Knowledge of medication name

    Time frame: 4-7 days

    The primary outcome was the patients ability to identify the medication name of their prescribed opioid pain reliever upon follow-up.

Secondary outcomes

  1. Knowledge and counseling recall outcomes

    Time frame: 4-7 days

    In addition to the outcome of medication name patients were asked additional knowledge and recall questions including: active ingredients in the medication, knowledge about safe daily dose of acetaminophen, side effects, recall of counseling about activities to avoid (drinking alcohol, driving vehicle), knowledge about addictive potential of the medication.

  2. Actual Use outcomes

    Time frame: 4-7 days

    Patients were queried about their home use of the medication including: pain score at home, average number of tabs per day, and satisfaction with pain reduction. Additionally they were asked about the timing of any alcohol consumption or driving in relation to the timing of medication dosing.

  3. Response to the intervention

    Time frame: 4-7 days

    Patients in the intervention arm were asked how they liked the intervention using a series of question with a Likert scale.

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Emergency Medicine Foundation

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Nov 24, 2014
Registry last updated
Aug 20, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.